awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34596353-79E1C11C-7CFA-41DC-BFCD-381D0B24018B
Q34596353-79E1C11C-7CFA-41DC-BFCD-381D0B24018B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34596353-79E1C11C-7CFA-41DC-BFCD-381D0B24018B
Tedizolid population pharmacokinetics, exposure response, and target attainment.
P2860
Q34596353-79E1C11C-7CFA-41DC-BFCD-381D0B24018B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34596353-79E1C11C-7CFA-41DC-BFCD-381D0B24018B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3d978a4c0ac050d3ece1f8b00f7d76dd61c2714c
P2860
Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.